362 related articles for article (PubMed ID: 33826221)
1. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.
Mu W; Muriello M; Clemens JL; Wang Y; Smith CH; Tran PT; Rowe PC; Francomano CA; Kline AD; Bodurtha J
Am J Med Genet A; 2019 Apr; 179(4):561-569. PubMed ID: 30703284
[TBL] [Abstract][Full Text] [Related]
3. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
[TBL] [Abstract][Full Text] [Related]
4. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
[TBL] [Abstract][Full Text] [Related]
5. Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers-Danlos syndrome clinic: A retrospective review.
McGillis L; Mittal N; Santa Mina D; So J; Soowamber M; Weinrib A; Soever L; Rozenberg D; Liu L; Tse Y; Katz J; Charames GS; Murphy K; Vadas P; Slepian MP; Walsh S; Wilson L; Adler A; Franzese A; Hussey L; Nevay DL; Guzman J; Clarke H
Am J Med Genet A; 2020 Mar; 182(3):484-492. PubMed ID: 31840928
[TBL] [Abstract][Full Text] [Related]
6. Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome.
Tai FWD; Palsson OS; Lam CY; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
Neurogastroenterol Motil; 2020 Dec; 32(12):e13975. PubMed ID: 32803794
[TBL] [Abstract][Full Text] [Related]
7. Severity classes in adults with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders: a pilot study of 105 Italian patients.
Copetti M; Morlino S; Colombi M; Grammatico P; Fontana A; Castori M
Rheumatology (Oxford); 2019 Oct; 58(10):1722-1730. PubMed ID: 30783660
[TBL] [Abstract][Full Text] [Related]
8. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
[TBL] [Abstract][Full Text] [Related]
9. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
[TBL] [Abstract][Full Text] [Related]
10. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
Thwaites PA; Gibson PR; Burgell RE
J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of kinesiophobia and its correlations with pain and fatigue in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type.
Celletti C; Castori M; La Torre G; Camerota F
Biomed Res Int; 2013; 2013():580460. PubMed ID: 23936820
[TBL] [Abstract][Full Text] [Related]
12. Dysautonomia in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders is associated with exercise intolerance and cardiac atrophy.
Ruiz Maya T; Fettig V; Mehta L; Gelb BD; Kontorovich AR
Am J Med Genet A; 2021 Dec; 185(12):3754-3761. PubMed ID: 34331416
[TBL] [Abstract][Full Text] [Related]
13. Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients: comparison of psychosocial and health variables.
Baeza-Velasco C; Bourdon C; Montalescot L; de Cazotte C; Pailhez G; Bulbena A; Hamonet C
Rheumatol Int; 2018 May; 38(5):871-878. PubMed ID: 29497845
[TBL] [Abstract][Full Text] [Related]
14. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
[TBL] [Abstract][Full Text] [Related]
15. Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.
Gensemer C; Burks R; Kautz S; Judge DP; Lavallee M; Norris RA
Dev Dyn; 2021 Mar; 250(3):318-344. PubMed ID: 32629534
[TBL] [Abstract][Full Text] [Related]
16. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
[TBL] [Abstract][Full Text] [Related]
17. The concomitant diagnosis of fibromyalgia and connective tissue disorders: A systematic review.
Alsiri N; Alhadhoud M; Alkatefi T; Palmer S
Semin Arthritis Rheum; 2023 Feb; 58():152127. PubMed ID: 36462303
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and impact of orthostatic intolerance in young women across the hypermobility spectrum.
Peebles KC; Tan I; Butlin M; Collins F; Tofts L; Avolio AP; Pacey V
Am J Med Genet A; 2022 Jun; 188(6):1761-1776. PubMed ID: 35224842
[TBL] [Abstract][Full Text] [Related]
19. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
Bennett SE; Walsh N; Moss T; Palmer S
Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Rashed ER; Ruiz Maya T; Black J; Fettig V; Kadian-Dodov D; Olin JW; Mehta L; Gelb BD; Kontorovich AR
Vasc Med; 2022 Jun; 27(3):283-289. PubMed ID: 35000503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
